MARIA G. BUSE, M.D.; DYRC F. SIBRANS, B.S.; JOHN BUSE, M.D.
Recent interest in unilateral renal disease as a cause of hypertension has prompted the development of several diagnostic tests. The renogram was the first attempt to use radioisotopes to compare the function of the two kidneys. However, this test did not indicate the relative sizes of the kidneys nor did it permit the visualization of parenchymal lesions. In 1959 Denneberg and Hedenskog (1) used I131-labeled sodium diatrizoate (Hypaque®) and iodopyracet (Diodrast®) for scintillation scanning of the kidneys. In 1960 McAfee and Wagner (2) proposed the use of chlormerodrin (Neohydrin®) labeled with radiomercury (Hg203), because it was highly concentrated in the
Learn more about subscription options.
Register Now for a free account.
BUSE MG, SIBRANS DF, BUSE J. Scintillation Scanning of Kidneys: A Pitfall of Interpretation in Renal Insufficiency. Ann Intern Med. 1964;60:857–865. doi: 10.7326/0003-4819-60-5-857
Download citation file:
Published: Ann Intern Med. 1964;60(5):857-865.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only